#news

Gene-editing Therapy CTX-001 Granted Priority Medicines Designation for Severe SCD in EU
Actualités

Gene-editing Therapy CTX-001 Granted Priority Medicines Designation for Severe SCD in EU

CTX001, an investigational gene-editing cell therapy, has been granted priority medicines (PRIME) designation by the European Medicines Agency (EMA) for the treatment of severe sickle cell disease (SCD). The announcement was made by CRISPR Therapeutics and Vertex Pharmaceuticals, which are jointly…
Iranian Blood Transfusion Organization Newsletter
Actualités

Iranian Blood Transfusion Organization Newsletter

The Iranian Blood Transfusion Organization (IBTO) and its most recent activities are featured on TIF’S website.
COVID-19 Update: Here’s Where We Stand Now In the Race For A Vaccine
Actualités

COVID-19 Update: Here’s Where We Stand Now In the Race For A Vaccine

As large parts of the world prepare for a second wave of coronavirus cases governments have pinned their hopes on the rapid development of a vaccine to provide a route…
TIF’s Latest Newsletter Issue Is Out!
Actualités

TIF’s Latest Newsletter Issue Is Out!

Our August 2020 newsletter has just been published! Read about our latest updates, including country activities, international projects, educational updates for patients with thalassaemia and haemoglobin disorders, and our novel…
AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt
Actualités

AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt

AstraZeneca Plc and the University of Oxford have resumed the British clinical trials of its Covid-19 vaccine, after the initial suspension over concerns with a participant who fell ill. University…
Thalassemics India News Update
Actualités

Thalassemics India News Update

The latest news from TIF’s Member  »Thalassemics India » in one place! In this issue you will find all the information on the new Thalassaemia Screening & Counselling Center in New…
AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine
Actualités

AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine

AstraZeneca Plc has begun final-stage, Phase III trial of its coronavirus vaccine AZD1222 in the U.S., according to the company´s latest statement. Trial centers across the US are recruiting up to 30,000 adults aged 18 years…
Malaysian Health Minister: The Country Needs More Geneticists to Detect Thalassaemia Early
Actualités

Malaysian Health Minister: The Country Needs More Geneticists to Detect Thalassaemia Early

Malaysia needs more geneticists in order to identify thalassaemia patients at an early stage, stated Health Minister Datuk Seri Dr Adham Baba, after launching the 2019 Malaysia Thalassaemia Registry (MTR)…
The eThalED Course Webinar Series Return With a New Session on Iron Monitoring in Thalassaemia
Actualités

The eThalED Course Webinar Series Return With a New Session on Iron Monitoring in Thalassaemia

TIF´s upcoming webinar on  »Iron Monitoring in Thalassaemia », specially designed and launched for medical specialists and healthcare professionals with a particular interest in the field of haemoglobin disorders and thalassaemia,…
IMR-687 Receives FDA Fast Track & Rare Pediatric Disease Designations for the Treatment of β-Τhalassaemia
Actualités

IMR-687 Receives FDA Fast Track & Rare Pediatric Disease Designations for the Treatment of β-Τhalassaemia

IMARA Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin, announced the U.S. Food and Drug…
Bouton retour en haut de la page